by
Gus Iversen, Editor in Chief | October 10, 2025
MediView XR, a Cleveland-based medical technology company specializing in augmented reality (AR) surgical visualization, has secured $24 million in Series A funding.
The round was led by GE HealthCare and included investments from Cleveland Clinic, Mayo Clinic, Edge Ventures (the investment arm of Emplify Health), and the JobsOhio Growth Capital Fund.
The financing will support MediView’s plans to expand clinical adoption, validate its technology in real-world settings, and scale operations globally. The company’s FDA-cleared AR navigation platform allows clinicians to view 3D representations of patient anatomy overlaid on the body during procedures, combining data from CT and live ultrasound imaging. The system is designed to improve surgical precision and reduce the cognitive effort required when interpreting traditional 2D imaging.
Ad Statistics
Times Displayed: 357
Times Visited: 1 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money.
“Our mission is to simplify, democratize, and inform medical procedures by giving clinicians intuitive, real-time 3D visualization and guidance tools,” said MediView CEO Mina Fahim. He added that partnerships with GE HealthCare, Cleveland Clinic, Mayo Clinic, and Emplify Health will accelerate both commercial and clinical expansion.
GE HealthCare executive Meraj Khan said the collaboration aligns with a shared goal of integrating advanced imaging with AR to improve procedural navigation. “We’re proud to help lead this funding round and redefine how clinicians visualize anatomy in real time,” Khan said.
The MediView platform, developed from intellectual property originating at Cleveland Clinic, aims to enhance workflow efficiency and collaboration during minimally invasive procedures such as biopsies, ablations, and injections. The technology also enables remote visualization and communication among clinicians, supporting both training and real-time decision-making.
MediView plans to use the new funding to advance product development, expand regulatory approvals, and build partnerships across medical imaging and therapeutic device sectors as it moves toward broader adoption of AR-assisted surgical navigation.
